Evidence map›Paper›PMID 38150360›Full record

ArticleJournal of medicinal chemistry2024

Novel Drug Screening Assay for

Susanna Haapanen, Harlan Barker, Fabrizio Carta, Claudiu T Supuran, Seppo Parkkila

Open access · hybridAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Susanna HaapanenFaculty of Medicine and Health Technology, Tampere University, FI-33520 Tampere, Finland.ORCID 0000-0003-3833-6629
Harlan BarkerFaculty of Medicine and Health Technology, Tampere University, FI-33520 Tampere, Finland.
Fabrizio CartaNeurofarba Department, Sezione di Chimica Farmaceutica e Nutraceutica, Università degli Studi di Firenze, Via U. Schiff 6, Sesto Fiorentino, I-50019 Firenze, Italy.ORCID 0000-0002-1141-6146
Claudiu T SupuranNeurofarba Department, Sezione di Chimica Farmaceutica e Nutraceutica, Università degli Studi di Firenze, Via U. Schiff 6, Sesto Fiorentino, I-50019 Firenze, Italy.ORCID 0000-0003-4262-0323
Seppo ParkkilaFaculty of Medicine and Health Technology, Tampere University, FI-33520 Tampere, Finland.
Tampere University · FIUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acanthamoeba castellaniiAmoebaCarbonic Anhydrase InhibitorsDrug Evaluation, PreclinicalCarbonic Anhydrase Inhibitors

Identifiers

PMID38150360
PMCPMC10788897
OpenAlexW4390265053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.